Best drug tests for DOT-industry employer screening

This is our default recommendation for employers in DOT-regulated industries who need an instant cup for the non-regulated screening they run alongside the regulated workflow. The 10-panel covers the five SAMHSA analytes that DOT-regulated testing screens (THC, cocaine, opiates, amphetamines, PCP) plus five additional analytes that most employer policies care about — benzodiazepines, barbiturates, methadone, MDMA, and oxycodone — at SAMHSA-aligned cutoffs.

The critical scope reminder: this device is not the DOT-regulated test itself. DOT-regulated specimen collection and testing under 49 CFR Part 40 is performed at an HHS-certified laboratory using the federal CCF, specified collection containers, and a regulated chain-of-custody workflow that includes a Medical Review Officer (MRO). Your DOT-qualified TPA handles that workflow. What this device handles is everything else — pre-employment screening that goes beyond DOT minimums, screening for non-safety-sensitive positions in your same workforce, supplemental screens before or after a regulated test, and any internal employer policy testing that sits outside the Part 40 framework. That is a meaningful volume in most trucking, transit, aviation, and logistics employer programs.

We ship same-day from US warehouse inventory and offer B2B procurement terms (volume pricing, NET 30 on approved credit) that match how transportation and logistics employers actually buy.

The 12-panel is the right choice when your collection desk runs a mixed workflow — some donors are DOT-regulated pre-employment (where the regulated test is at the lab and the instant cup is supplemental), some donors are non-DOT employer pre-employment (where the instant cup is the primary screen), and some donors are clinical or occupational health. The wider panel covers more of what those workflows actually need without forcing you to stock multiple SKUs.

The clicker variant is worth the small premium when your collection desk has any chance of a 10+ minute gap between voiding and read — common in busy occupational-health offices. The tapered variant is the right choice when your collectors read on the spot every time and unit cost matters at volume.

Confirm BioSciences is an established manufacturer in this market, and the DrugConfirm Advanced cup line sits in the same FDA-cleared, CLIA-waived category as the other major manufacturers' point-of-care immunoassay devices. The brand is available through more than one distribution channel.

If you are evaluating this brand against ours, the meaningful comparison is per-unit cost at your projected annual volume, lead time on stocked SKUs, and B2B procurement terms (volume tiers, NET 30, PO acceptance). Spec-sheet differences across major manufacturers in this category tend to be small; procurement experience varies more. Verify current specifications, certifications, and pricing directly with the manufacturer.

Premier Biotech publishes both a urine cup line (CupTox) and oral-fluid devices on their site. For employers whose workflow includes both matrices — for example, urine for pre-employment and oral fluid for reasonable-suspicion where authorized by policy and applicable regulations — single-vendor consolidation can simplify procurement.

Oral-fluid testing's role in DOT-regulated workflows has evolved over the past several years and is governed by federal rulemaking; confirm the current state with your DOT-qualified TPA before standardizing on a matrix for any DOT-regulated program. For employers that are urine-only, the case for switching specifically to CupTox over a vendor focused on the urine market is weaker — evaluate on per-unit cost, lead time, and B2B terms. Verify current product specifications and certifications directly with the manufacturer.

Phamatech's publicly available materials indicate the company offers both a device-manufacturing line and laboratory services. For smaller employers without an established TPA or lab relationship, the bundled workflow can simplify procurement. For larger DOT-industry employers, the TPA arrangement already handles the lab piece, so the bundle is less of a differentiator and the evaluation comes down to the device on its own merits.

AccuTest as a standalone point-of-care device sits in the same FDA-cleared, CLIA-waived category as ours and the other major manufacturers. As with the other competitor entries, verify current product specifications, certifications, lab status, and B2B procurement terms directly with the manufacturer.